← Leaderboards
Otelio S Randall
Howard University
$3,754,787
Attributed
$3,754,787
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631.8K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,754,787 · 11
By mechanism
M01$2,624,376 · 10
U01$1,130,411 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectAfrican AmericanClinical ResearchHuman Therapy EvaluationBlood PressureAntihypertensive AgentsCardiovascular Disorder ChemotherapyHypertensionClinical TrialsKidney FunctionChronic Renal FailureRenal HypertensionAce InhibitorsLongitudinal Human StudyBeta Antiadrenergic AgentCooperative StudyResearch PersonnelCalcium Channel BlockersGlomerular Filtration RateDisease /Disorder Proneness /RiskPatient Oriented ResearchAmlodipineCardiovascular Disorder RiskComputer Retrieval Of Information On Scientific Projects Database
Grant awards (25)
MOMHAA$631,769
M01 · FY2009 · RR · contact PI
AASK-CO$42,200
M01 · FY2008 · RR · contact PI
MOMHAA$2,553
M01 · FY2008 · RR · contact PI
AASK-CO$123,168
M01 · FY2007 · RR · contact PI
AASK Cohort Study$29,581
U01 · FY2007 · DK · contact PI
AASK-CO$143,439
M01 · FY2006 · RR · contact PI
AASK Cohort Study$117,639
U01 · FY2006 · DK · contact PI
TM--STUDY #2$176,772
M01 · FY2005 · RR
AASK Cohort Study$120,470
U01 · FY2005 · DK
HERBAL STUDY$92,900
M01 · FY2005 · RR
AASK-CO$79,894
M01 · FY2005 · RR
IMT Study$453,454
M01 · FY2004 · RR
Herbal Study$216,848
M01 · FY2004 · RR
AASK Cohort Study$120,470
U01 · FY2004 · DK
AASK Cohort Study$42,686
M01 · FY2004 · RR
AASK Cohort Study$120,470
U01 · FY2003 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION$98,441
U01 · FY2002 · DK
LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)$0
M01 · FY2002 · RR
EVALUATION &REDUCTION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE (OB$0
M01 · FY2002 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)$0
M01 · FY2002 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION$256,458
U01 · FY2001 · DK
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE &HYPERTENSION$266,882
U01 · FY2000 · DK
LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION (LIFE)$206,231
M01 · FY2000 · RR
EVALUATION &REDUCTION OF RISK FACTORS FOR CARDIOVASCULAR DISEASE (OB$206,231
M01 · FY2000 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)$206,231
M01 · FY2000 · RR